title: A dual role for the immune response in a mouse model of inflammation-associated lung cancer.
abstract: Lung cancer is the leading cause of cancer death worldwide. Both principal factors known to cause lung cancer, cigarette smoke and asbestos, induce pulmonary inflammation, and pulmonary inflammation has recently been implicated in several murine models of lung cancer. To further investigate the role of inflammation in the development of lung cancer, we generated mice with combined loss of IFN-γ and the β-common cytokines GM-CSF and IL-3. These immunodeficient mice develop chronic pulmonary inflammation and lung tumors at a high frequency. Examination of the relationship between these tumors and their inflammatory microenvironment revealed a dual role for the immune system in tumor development. The inflammatory cytokine IL-6 promoted optimal tumor growth, yet wild-type mice rejected transplanted tumors through the induction of adaptive immunity. These findings suggest a model whereby cytokine deficiency leads to oncogenic inflammation that combines with defective antitumor immunity to promote lung tumor formation, representing a unique system for studying the role of the immune system in lung tumor development.
authors.affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA.
authors.forename: Michael
authors.initials: M
authors.lastname: Dougan
authors.forename: Danan
authors.initials: D
authors.lastname: Li
authors.forename: Donna
authors.initials: D
authors.lastname: Neuberg
authors.forename: Martin
authors.initials: M
authors.lastname: Mihm
authors.forename: Paul
authors.initials: P
authors.lastname: Googe
authors.forename: Kwok-Kin
authors.initials: KK
authors.lastname: Wong
authors.forename: Glenn
authors.initials: G
authors.lastname: Dranoff
mesh_terms: D000230:Adenocarcinoma / Q000209:etiology* / Q000235:genetics / Q000276:immunology; D000818:Animals; D019898:Autocrine Communication; D004195:Disease Models, Animal; D006084:Graft Rejection / Q000276:immunology; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000172:deficiency / Q000235:genetics; D018380:Hematopoietic Stem Cell Transplantation; D007121:Immunocompetence; D007153:Immunologic Deficiency Syndromes / Q000150:complications / Q000235:genetics; D007249:Inflammation / Q000150:complications* / Q000276:immunology; D007371:Interferon-gamma / Q000172:deficiency / Q000235:genetics; D007377:Interleukin-3 / Q000172:deficiency / Q000235:genetics; D015850:Interleukin-6 / Q000235:genetics / Q000502:physiology; D008175:Lung Neoplasms / Q000209:etiology* / Q000235:genetics / Q000276:immunology; D020935:MAP Kinase Signaling System; D051379:Mice; D008807:Mice, Inbred BALB C; D018345:Mice, Knockout; D016328:NF-kappa B / Q000037:antagonists & inhibitors / Q000502:physiology; D009368:Neoplasm Transplantation; D011828:Radiation Chimera / Q000276:immunology; D050796:STAT3 Transcription Factor / Q000502:physiology; D000093242:Interleukin-6 Inhibitors
chemical_list: D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D007371:Interferon-gamma; D007377:Interleukin-3; D015850:Interleukin-6; D016328:NF-kappa B; D050796:STAT3 Transcription Factor; D000093242:Interleukin-6 Inhibitors; C494087:Stat3 protein, mouse